Home »
Academic Articles & Research Papers
Showing 20 of 21 academic articles
Nakazawa S, Sakai K, Fukai K, Furuya Y et al. • BMC public health
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1186/s12889-026-28932-7
PMC: PMC13729562
Han N, Liu H, Yan L, Tang H • Frontiers in public health
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fpubh.2026.1972004
PMC: PMC13727557
Song Q, Wang L, Jiang J, Liu W • BMC primary care
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1186/s12875-026-03513-0
PMC: PMC13732994
Kohlmaier B, Indolfi G, Baumann U, Gonçalves C et al. • Journal of pediatric gastroenterology and nutrition
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1002/jpn3.70543
PMC: PMC13736125
Wang J, Xu J, Meng J, Shi X et al. • Journal of gastrointestinal oncology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.21037/jgo-2026-0202
PMC: PMC13546560
Xie C, Wang B, Wang Y, Zhao G et al. • Journal of veterinary science
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.4142/jvs.25210
PMC: PMC13655562
Saxena R, Varshney S, Khan MS, Bansal M et al. • Cureus
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.7759/cureus.117388
PMC: PMC13726377
Bo Cai, Shixue Chang, Yuhan Tian, Shuai Zhen • Immunity, Inflammation and Disease
(2023)
Abstract Hepatitis B virus (HBV) infection remains a global health challenge. Despite the availability of effective preventive vaccines, millions of people are at risk of cirrhosis and hepatocellular carcinoma. Current drug therapies inhibi...
DOAJ
Open Access (DOAJ)
DOI: 10.1002/iid3.866
Haiting Jiang, Chengyu Wei • Frontiers in Public Health
(2024)
China, with the severe burden of hepatitis B, plays a significant role in the global efforts towards eliminating hepatitis B disease by 2030. Vaccination is recognized as the most effective measure to prevent infectious diseases. However, v...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fpubh.2024.1286801
Tutu Kalita, Saba Abbasi Dezfouli, Lalit M. Pandey, Hasan Uludag • Pharmaceutics
(2022)
RNAi (RNA interference)-based technology is emerging as a versatile tool which has been widely utilized in the treatment of various diseases. siRNA can alter gene expression by binding to the target mRNA and thereby inhibiting its translati...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/pharmaceutics14112520
Nafiseh Hajian Afarani, Fatemeh Keshavarzi, Kahin Shahanipour, Seyed Amir Zarei • Scientific Reports
(2025)
Abstract Tenofovir is an antiviral drug that prevents the replication of AIDS and hepatitis B viruses. To minimize the harmful side effects of the drug on the body, it is essential to determine its precise concentration in the blood. Fluore...
DOAJ
Open Access (DOAJ)
DOI: 10.1038/s41598-025-08877-4
S Yu Milovanova, L V Lysenko (Kozlovskaya), L Yu Milovanova, N N Mrykhin et al. • Терапевтический архив
(2018)
Hepatitis C virus (HCV) is a global population problem due to its high prevalence, usually late diagnosis, the difficulties of treatment. In the prognosis of patients with HCV not only hepatic, but increasingly frequent of extrahepatic HCV ...
DOAJ
Open Access (DOAJ)
DOI: 10.26442/terarkh2018906112-120
Li Tao, Xiaomeng Ren, Wenhui Zhai, Zheng Chen • Molecules
(2022)
Non-canonical nuclear factor kappa B (NF-κB) signaling pathway regulates many physiological and pathological processes, including liver homeostasis and diseases. Recent studies demonstrate that non-canonical NF-κB signaling pathway plays an...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/molecules27134275
Sukran Kose, Gulfem Ece, Ayhan Gozaydin, Melda Turken • Journal of Infection in Developing Countries
(2012)
Introduction: Hepatitis delta virus (HDV) is an incomplete virus dependent on hepatitis B virus (HBV) for its multiplication. It can infect individuals with active HBV infection and cause severe liver disease. It is less prevalent than hepa...
DOAJ
Open Access (DOAJ)
DOI: 10.3855/jidc.1749
Laura J. Frost, Michael R. Reich • Health Affairs
(2009)
Many people in developing countries lack access to health technologies. We present seven findings about processes that shape access, based on analysis of six case histories: praziquantel to treat schistosomiasis (a parasitic worm disease), ...
OPENALEX
DOI: https://doi.org/10.1377/hlthaff.28.4.962
Peng Wang, Ying Li, Lu Li, Rong Zhong et al. • Frontiers in Oncology
(2021)
ObjectiveA hot genetic variant, rs641738 within the membrane-bound O-acyltransferase domain containing 7(MBOAT7) and transmembrane channel-like 4 (TMC4), was recently reported to be associated with several liver diseases. However, the resul...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fonc.2021.639438
Zelin Tian, Chen Xu, Peijun Yang, Zhibin Lin et al. • Frontiers in Immunology
(2022)
Hepatocellular carcinoma(HCC) is the sixth most common cancer in the world and is usually caused by viral hepatitis (HBV and HCV), alcoholic, and non-alcoholic fatty liver disease(NAFLD). Viral hepatitis accounts for 80% of HCC cases worldw...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2022.984728
Joon Wah Mak, B A Khalid • PubMed
(1992)
In recent years medical research, utilising biotechnology and related tools, has contributed significantly to advances in the laboratory diagnosis of infectious diseases and hormonal disorders in Malaysia, The main thrust was in the develop...
OPENALEX
Na Guo, Jian Wang, Stephen Nicholas, Elizabeth Maitland et al. • Vaccines
(2020)
Understanding behavioral factors differences in the preferences for vaccinations can improve predictions of vaccine uptake rates and identify effective policy interventions to increase the demand for vaccinations. In this study, 353 adults ...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/vaccines8030527
Kuniyasu Niizuma, Yoshikazu Ogawa, Takayuki Kogure, Teiji Tominaga • BMC Infectious Diseases
(2020)
Abstract Background Hepatitis B virus (HBV) infection is a major public health problem worldwide. More than 2 billion people have been exposed to HBV, and about 257 million individuals are chronic carriers of HBV. HBV reactivation has been ...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12879-020-04971-2